White Matter Degeneration—A Treatable Target?-Reference-Cited by-同舟云学术

White Matter Degeneration—A Treatable Target?

Published:2020-07-01 Issue:7 Volume:77 Page:793
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Roseborough Austyn¹,Hachinski Vladimir²,Whitehead Shawn¹

Affiliation:

1. Department of Anatomy and Cell Biology, Western University, London, Ontario, Canada

2. Deparment of Clinical Neurological Sciences, Western University, London, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2764333/jamaneurology_roseborough_2020_vp_200005.pdf

Reference9 articles.

1. Classification and epidemiology of MCI.;Roberts;Clin Geriatr Med,2013

2. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.;Debette;BMJ,2010

3. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48.;Wen;Hum Brain Mapp,2009

4. Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: preventing dementia by preventing stroke: the Berlin Manifesto.;Hachinski;Int J Stroke

5. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer’s disease.;Marshall;Alzheimers Dement,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linking sarcopenia, brain structure and cognitive performance: a large-scale UK Biobank study;Brain Communications;2024

2. BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality;Journal of Lipid and Atherosclerosis;2024

3. White matter abnormalities mediate the association between masticatory dysfunction and cognition among older adults;Journal of Oral Rehabilitation;2023-09-14

4. The Ties That Bind: Glial Transplantation in White Matter Ischemia and Vascular Dementia;Neurotherapeutics;2022-11-10

5. Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury;Acta Neuropathologica Communications;2022-05-02